Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000248616 | SCV000316136 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000248616 | SCV000331735 | benign | not specified | 2015-12-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000289860 | SCV000450114 | benign | Ellis-van Creveld syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000289860 | SCV000484088 | benign | Ellis-van Creveld syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000347215 | SCV000484089 | benign | Curry-Hall syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000248616 | SCV000516345 | benign | not specified | 2016-04-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV001812742 | SCV000885376 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001511703 | SCV001718988 | benign | Ellis-van Creveld syndrome; Curry-Hall syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001812742 | SCV005304803 | benign | not provided | criteria provided, single submitter | not provided |